touchREVIEWS in RMD is an international, peer-reviewed, free-to-access journal dedicated to the timely publication of review articles, original research articles, and editorials in the field of rheumatology.
Designed to support time-pressured physicians, clinicians, nurses, general practitioners and related healthcare professionals involved in the management of rheumatic and musculoskeletal disorders, touchREVIEWS in RMD addresses the most important and salient developments in the field.
Editor-in-Chief: Peter C. Taylor, Professor of Musculoskeletal Sciences at the University of Oxford, Oxford, UK.
Electronic ISSN: 2635-1420 DOI: doi.org/10.17925
Established: January 2021 Frequency: Bi-annual
Don’t forget to register to be notified about articles as soon as they are published
CAR T Cell Therapy: A New Hope for Refractory Lupus?
touchREVIEWS in RMD. 2023;2(2):Online ahead of journal publication
Systemic lupus erythematosus (SLE) is a multisystem, autoimmune disorder affecting skin, joints, kidneys, the heart, lungs, the brain and blood cells, and is characterized by heterogeneous presentations and severity. It is more common in females than males, with a ratio of 9:1, and it is associated with significant morbidity and mortality.1 Despite recent novel therapies […]
Foreword – touchREVIEWS in RMD, Volume 2, Issue 1, 2023
Welcome to the latest issue of touchREVIEWS in RMD, which aims to provide healthcare professionals with a wide range of topical articles in the field of rheumatic and musculoskeletal diseases (RMDs). We begin with an informative practice pearl from Sun and Pope. This paper examines the potential solutions to integrate into clinical practice that may […]
Strategies to Improve Adherence in Patients with Rheumatoid Arthritis
touchREVIEWS in RMD. 2023;2(1):2–3 DOI: https://doi.org/10.17925/RMD.2023.2.1.2
Rheumatoid arthritis (RA) is a chronic, autoimmune, inflammatory disease that affects synovial joints but may be accompanied by systemic and extra-articular manifestations.1,2 Patients with RA are associated with a higher mortality rate compared with the general population and with increased socioeconomic burden from lost productivity at work, disability and cost of treatment.3 Therefore, appropriate disease management is […]
An Update on Biosimilars in Rheumatic and Musculoskeletal Disorders
touchREVIEWS in RMD. 2023;2(1):46–49 DOI: https://doi.org/10.17925/RMD.2023.2.1.46
Biologics are medications derived from biological sources used to treat several immune-mediated inflammatory diseases. These medications interfere with autoimmune processes by inhibiting specific molecular or cellular targets. They are highly effective medications, mostly used in cases of moderate-to-severe disease activity. As such, biologics have revolutionized the treatment of and transformed outcomes for patients with rheumatological […]
The Adaption and Validation Processes in Remission Criteria for Rheumatoid Arthritis
touchREVIEWS in RMD. 2023;2(1):4–6 DOI: https://doi.org/10.17925/RMD.2023.2.1.4
Standardization of the assessment of disease activity in patients with rheumatoid arthritis (RA) has made a big difference in the comparability of clinical trials and in treatment processes in clinical practice.1–3 Disease activity is the underlying driver for radiographic progression, and functional limitations and functional disabilities may also evolve by progressive structural damage.4,5 The introduction of composite […]
Bimekizumab, a Humanized Monoclonal Immunoglobulin G1 Antibody for the Treatment of Psoriatic Arthritis: A Systematic Review
touchREVIEWS in RMD. 2023;2(1):11–16
Psoriatic arthritis (PsA) is a typical complication of psoriasis (PSO) that is often accompanied by nail PSO, vertebral and/or pelvic involvement, enthesitis and iritis. PsA leads to the destruction and/or ankylosis of the peripheral joints or spine, resulting in poor quality of life.1 Interleukin (IL)-23, IL-17 and tumour necrosis factor (TNF) play a pivotal role in […]
Health Equity in Rheumatology: A Global Health Perspective
touchREVIEWS in RMD. 2023;2(1):42–45 DOI: https://doi.org/10.17925/RMD.2023.2.1.42
The preamble of the World Health Organization’s constitution defines health as “a state of complete physical, mental and social wellbeing, and not merely the absence of disease or infirmity”.1 An optimal state of health is considered a fundamental human right. When each human has the ability and opportunity to attain optimal health, only then can a […]
Challenges in Family Planning and Pregnancy for Women with Rheumatic Diseases
touchREVIEWS in RMD. 2023;2(1):28–36 DOI: https://doi.org/10.17925/RMD.2023.2.1.28
Systemic rheumatic diseases (RDs) commonly arise during a woman’s reproductive years and may have implications for family planning and pregnancy. Among the RDs, systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are classically associated with an increased risk of adverse pregnancy outcomes (APOs), including miscarriage, foetal loss, preeclampsia, intrauterine growth restriction (IUGR) and preterm delivery.1–4 Although SLE pregnancy outcomes have improved over time, maternal mortality remains higher in women […]
Managing Inflammatory Bowel Disease in Spondyloarthritis
touchREVIEWS in RMD. 2023;2(1):7–10 DOI: https://doi.org/10.17925/RMD.2023.2.1.7
Spondyloarthritides are chronic rheumatic diseases associated with diverse extra-articular manifestations, such as psoriasis, uveitis and inflammatory bowel diseases (IBDs), namely Crohn’s disease (CD) and ulcerative colitis (UC). Historically, spondyloarthritis (SpA) was divided into several subcategories, namely, ankylosing spondylitis (AS), psoriatic arthritis, enteropathic arthritis, reactive arthritis and undifferentiated spondyloarthropathy. Given the possible overlap between these different entities, it is now preferred to use a phenotypic classification, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchIMMUNOLOGYSign me up!